BiotechTube

Eperisone

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Muscle Spasm; Back Pain

Conditions

Muscle Spasm; Back Pain

Trial Timeline

Apr 1, 2006 → Jun 1, 2006

NCT ID
NCT00327730

About Eperisone

Eperisone is a phase 3 stage product being developed by Eisai for Muscle Spasm; Back Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT00327730. Target conditions include Muscle Spasm; Back Pain.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00327730Phase 3Completed

Competing Products

20 competing products in Muscle Spasm; Back Pain

See all competitors
ProductCompanyStageHype Score
pegylated liposomal doxorubicin (PLD) + PD-1CSPC Pharmaceutical Group LimitedPhase 2
51
Enfortumab vedotin + PembrolizumabAstellas PharmaPhase 2
52
Enfortumab Vedotin + PembrolizumabAstellas PharmaPhase 2
52
Pembrolizumab + Enfortumab VedotinAstellas PharmaPhase 3
77
LY2495655 + PlaceboEli LillyPhase 2
52
HRS-9190Jiangsu Hengrui MedicinePhase 1
33
HRS-9190 for InjectionJiangsu Hengrui MedicinePhase 1
33
Botulinum Toxin Type AAbbViePhase 3
77
BOTOX + PlaceboAbbViePhase 3
77
BOTOX + PlaceboAbbViePhase 3
77
BOTOX + Placebo for BOTOXAbbViePhase 3
77
BOTOX + PlaceboAbbViePhase 3
77
Durvalumab + Tremelimumab + Enfortumab VedotinAstraZenecaPhase 3
77
Durvalumab (MEDI4736) + Bacillus Calmette-Guerin (BCG)AstraZenecaPhase 3
77
Durvalumab + OleclumabAstraZenecaPhase 1
33
AZD4547 + MEDI4736 + Olaparib + AZD1775 + Vistusertib + AZD9150 + SelumetinibAstraZenecaPhase 1
33
Durvalumab + Cisplatin + GemcitabineAstraZenecaPhase 3
77
Durvalumab + BCGAstraZenecaPhase 3
77
Durvalumab + MonalizumabAstraZenecaPhase 2
52
Durvalumab (Imfinzi) + TremelimumabAstraZenecaPhase 2
52

Other Products from Eisai

MecobalaminApproved
85
MonteplaseApproved
85
E2020 + PlaceboApproved
85
Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IVApproved
85
DonepezilApproved
85